Vitamin D enhances erlotinib response in EGFR-mutant non-small cell lung cancer

被引：0
|
作者：
Shaurova, Tatiana
Shoemaker, Suzanne F.
Hershberger, Pamela A.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4674
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4674
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Osimertinib for EGFR-mutant non-small cell lung cancer: place in therapy and future perspectives
    Ricciuti, Biagio
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S249 - S252
  • [42] Impact of Asian ethnicity on outcome in metastatic EGFR-mutant non-small cell lung cancer
    Gibson, Amanda J. W.
    D'Silva, Adrijana
    Elegbede, Anifat A.
    Tudor, Roxana A.
    Dean, Michelle L.
    Bebb, Dafydd Gwyn
    Hao, Desiree
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (06) : 343 - 352
  • [43] Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic review
    Attili, Ilaria
    Passaro, Antonio
    Corvaja, Carla
    Aliaga, Pamela Trillo
    Del Signore, Ester
    Spitaleri, Gianluca
    de Marinis, Filippo
    CANCER TREATMENT REVIEWS, 2023, 119
  • [44] Cranial irradiation in patients with EGFR-mutant non-small cell lung cancer brain metastases
    Yang, T. Jonathan
    Wu, Abraham J.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 134 - 137
  • [45] The role of PD-L1 in EGFR-mutant non-small cell lung cancer
    Gao, Wentao
    Wang, Lingling
    Zhao, Yanyan
    Zhu, Lucheng
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [46] Immunotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: End of the Road or the First Chapter?
    Ketpueak, Thanika
    Tan, Daniel S. W.
    Popat, Sanjay
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (34)
  • [47] OLIMPIA dataset: Radiomics to predict outcomes in EGFR-mutant non-small cell lung cancer
    Perez, G.
    Minatta, J. N.
    Aineseder, M.
    Mosquera, C.
    Benitez, S. E.
    ANNALS OF ONCOLOGY, 2022, 33 : S18 - S18
  • [48] Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
    Kim, Soomin
    Koh, Jaemoon
    Kim, Tae Min
    Oh, Songji
    Kim, Soyeon
    Youk, Jeonghwan
    Kim, Miso
    Keam, Bhumsuk
    Jeon, Yoon Kyung
    Kim, Dong-Wan
    Heo, Dae Seog
    ISCIENCE, 2025, 28 (02)
  • [49] ll-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer
    Xu, Cong
    Jiang, Ze-Bo
    Shao, Le
    Zhao, Zi-Ming
    Fan, Xing-Xing
    Sui, Xinbing
    Yu, Li-Li
    Wang, Xuan-Run
    Zhang, Ruo-Nan
    Wang, Wen-Jun
    Xie, Ya-Jia
    Zhang, Yi-Zhong
    Nie, Xiao-Wen
    Xie, Chun
    Huang, Ju-Min
    Wang, Jing
    Wang, Jue
    Leung, Elaine Lai-Han
    Wu, Qi-Biao
    PHARMACOLOGICAL RESEARCH, 2023, 191
  • [50] Bevacizumab plus erlotinib versus erlotinib alone for advanced EGFR-mutant non-small cell lung cancer: a meta-analysis of randomized clinical trials
    Ruijian Li
    Weiyi Li
    Fang Zhang
    Shanshan Li
    European Journal of Medical Research, 28
12345